Boston Partners lowered its position in shares of Morgan Stanley (NYSE:MS) by 10.6% in the fourth quarter, Holdings Channel reports. The fund owned 368,134 shares of the financial services provider’s stock after selling 43,750 shares during the period. Boston Partners’ holdings in Morgan Stanley were worth $19,316,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Baxter Bros Inc. raised its position in shares of Morgan Stanley by 15.9% during the fourth quarter. Baxter Bros Inc. now owns 43,070 shares of the financial services provider’s stock worth $2,260,000 after acquiring an additional 5,900 shares during the last quarter. CIBC World Markets Inc. raised its position in shares of Morgan Stanley by 192.7% during the fourth quarter. CIBC World Markets Inc. now owns 388,738 shares of the financial services provider’s stock worth $20,397,000 after acquiring an additional 255,925 shares during the last quarter. Engineers Gate Manager LP raised its position in shares of Morgan Stanley by 105.4% during the fourth quarter. Engineers Gate Manager LP now owns 30,994 shares of the financial services provider’s stock worth $1,626,000 after acquiring an additional 15,906 shares during the last quarter. Quantitative Systematic Strategies LLC bought a new stake in shares of Morgan Stanley during the fourth quarter worth $1,422,000. Finally, Iberiabank Corp grew its stake in shares of Morgan Stanley by 11.8% during the fourth quarter. Iberiabank Corp now owns 9,121 shares of the financial services provider’s stock worth $479,000 after purchasing an additional 960 shares during the period. Institutional investors own 86.63% of the company’s stock.

Morgan Stanley (MS) opened at $51.79 on Friday. Morgan Stanley has a 52 week low of $40.06 and a 52 week high of $58.05. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 2.68. The stock has a market capitalization of $93,630.00, a PE ratio of 16.76, a price-to-earnings-growth ratio of 0.94 and a beta of 1.54.

Morgan Stanley (NYSE:MS) last posted its earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. The firm had revenue of $9.50 billion during the quarter, compared to analysts’ expectations of $9.25 billion. During the same period in the previous year, the firm earned $0.81 earnings per share. The company’s revenue was up 5.3% on a year-over-year basis. equities research analysts predict that Morgan Stanley will post 4.51 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st will be paid a $0.25 dividend. The ex-dividend date of this dividend is Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.93%. Morgan Stanley’s payout ratio is 32.36%.

A number of equities research analysts recently commented on the company. Societe Generale set a $61.00 price objective on Morgan Stanley and gave the stock a “neutral” rating in a research note on Monday, January 22nd. Royal Bank of Canada reaffirmed a “buy” rating and set a $60.00 price objective on shares of Morgan Stanley in a research note on Friday, January 19th. UBS Group raised Morgan Stanley to an “overweight” rating in a research note on Wednesday, January 10th. Atlantic Securities raised Morgan Stanley from a “neutral” rating to an “overweight” rating and set a $61.00 price objective for the company in a research note on Wednesday, January 10th. Finally, Vining Sparks reaffirmed a “buy” rating and set a $60.00 price objective on shares of Morgan Stanley in a research note on Monday, January 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $54.07.

In other news, Director Alistair Darling sold 3,850 shares of the company’s stock in a transaction dated Friday, November 24th. The stock was sold at an average price of $49.29, for a total transaction of $189,766.50. Following the completion of the transaction, the director now directly owns 14,218 shares of the company’s stock, valued at $700,805.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Keishi Hotsuki sold 25,000 shares of the company’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $50.00, for a total value of $1,250,000.00. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

WARNING: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.dailypolitical.com/2018/02/09/morgan-stanley-ms-shares-sold-by-boston-partners.html.

Morgan Stanley Profile

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.